FARN

FARON PHARMACEUTICALS OY ORD NPV (DI)

TitleTime
Publication in Intensive Care MedicineWed 20/05/20 | 07:00
Results of the Annual General MeetingMon 18/05/20 | 16:00
Exercise of optionsWed 13/05/20 | 13:00
Managers? transactionsTue 12/05/20 | 18:00
Faron receives grant from Business FinlandMon 11/05/20 | 10:00
Clevegen manufacturing agreementTue 05/05/20 | 07:00
Holding(s) in CompanyWed 29/04/20 | 13:15
Holding(s) in CompanyMon 27/04/20 | 14:45
Traumakine to be a part of WHO?s Solidarity trialMon 27/04/20 | 07:00
Update on results of Placing and issue of equityThu 23/04/20 | 13:00
Result of placing and issue priceWed 22/04/20 | 07:00
Proposed PlacingTue 21/04/20 | 16:45
Second Price Monitoring ExtnWed 15/04/20 | 11:06
Price Monitoring ExtensionWed 15/04/20 | 11:00
Notice of Annual General MeetingTue 14/04/20 | 07:00
AGM to be postponedFri 03/04/20 | 14:45
REMAP-CAP to study IFN beta-1a effect in COVID-19Wed 01/04/20 | 07:00
Part 1 of the MATINS Phase I/II Study CompletedMon 30/03/20 | 07:00
Correction to Faron´s Annual Report 2019Thu 26/03/20 | 10:00
Faron´s Annual Report 2019 publishedWed 25/03/20 | 07:28
Notice of Annual General MeetingFri 20/03/20 | 11:30
Final Results for the year ended December 31, 2019Fri 20/03/20 | 07:00
Second Price Monitoring ExtnThu 19/03/20 | 16:41
Price Monitoring ExtensionThu 19/03/20 | 16:36
Second Price Monitoring ExtnThu 12/03/20 | 16:44
Price Monitoring ExtensionThu 12/03/20 | 16:38
FDA accepts protocol for new Traumakine trialMon 09/03/20 | 07:00
MATINS updateThu 05/03/20 | 07:00
Faron to acquire AOC3 antagonist platformMon 02/03/20 | 07:00
Price Monitoring ExtensionWed 26/02/20 | 07:05
Second Price Monitoring ExtnWed 26/02/20 | 07:01
Price Monitoring ExtensionWed 26/02/20 | 07:00
Second Price Monitoring ExtnTue 25/02/20 | 14:05
Price Monitoring ExtensionTue 25/02/20 | 14:00
Price Monitoring ExtensionTue 25/02/20 | 11:00
Second Price Monitoring ExtnMon 24/02/20 | 16:41
Price Monitoring ExtensionMon 24/02/20 | 16:35
Second Price Monitoring ExtnTue 18/02/20 | 11:06
Price Monitoring ExtensionTue 18/02/20 | 11:00
Second Price Monitoring ExtnTue 18/02/20 | 09:05
Price Monitoring ExtensionTue 18/02/20 | 09:00
Traumakine updateThu 06/02/20 | 07:00
Ovarian cancer selected as 2nd MATINS trial cohortMon 27/01/20 | 07:00
DMC approves colorectal cancer cohort expansionMon 13/01/20 | 07:00
Update on Traumakine drug substance manufacturingMon 30/12/19 | 09:30
Price Monitoring ExtensionThu 12/12/19 | 14:00
Matins Trial UpdateWed 11/12/19 | 07:00
Second Price Monitoring ExtnMon 02/12/19 | 14:06
Price Monitoring ExtensionMon 02/12/19 | 14:00
Second Price Monitoring ExtnFri 29/11/19 | 14:05
Price Monitoring ExtensionFri 29/11/19 | 14:00
LIQUIDITY PROVIDING AGREEMENTFri 29/11/19 | 07:31
Company Description & information on cash positionFri 29/11/19 | 07:30
Second Price Monitoring ExtnThu 28/11/19 | 09:05
Price Monitoring ExtensionThu 28/11/19 | 09:00
FDA has approved Faron's Clevegen INDThu 28/11/19 | 07:00
Faron´s financial calendar for 2020Wed 27/11/19 | 16:00
Holdings in CompanyThu 21/11/19 | 14:00
Price Monitoring ExtensionThu 21/11/19 | 09:00
Application to Nasdaq First North Growth MarketThu 21/11/19 | 07:15
Second Price Monitoring ExtnTue 19/11/19 | 11:05
Price Monitoring ExtensionTue 19/11/19 | 11:00
Second Price Monitoring ExtnFri 15/11/19 | 11:06
Price Monitoring ExtensionFri 15/11/19 | 11:00
Registration of SharesTue 12/11/19 | 15:45
Results of Placing and Issue PriceFri 08/11/19 | 07:00
Proposed Placing and Financial Adviser AppointmentThu 07/11/19 | 16:51
Second Price Monitoring ExtnTue 05/11/19 | 16:40
Price Monitoring ExtensionTue 05/11/19 | 16:36
Second Price Monitoring ExtnTue 05/11/19 | 14:05
Price Monitoring ExtensionTue 05/11/19 | 14:00
Second Price Monitoring ExtnTue 05/11/19 | 11:05
Price Monitoring ExtensionTue 05/11/19 | 11:00
Second Price Monitoring ExtnTue 05/11/19 | 09:05
Price Monitoring ExtensionTue 05/11/19 | 09:00
Price Monitoring ExtensionMon 04/11/19 | 16:35
Second Price Monitoring ExtnMon 04/11/19 | 14:05
Price Monitoring ExtensionMon 04/11/19 | 14:00
Statement regarding Price MovementFri 01/11/19 | 14:15
Second Price Monitoring ExtnFri 01/11/19 | 14:05
Price Monitoring ExtensionFri 01/11/19 | 14:00
Second Price Monitoring ExtnFri 01/11/19 | 11:06
Price Monitoring ExtensionFri 01/11/19 | 11:00
Price Monitoring ExtensionThu 31/10/19 | 16:35
Results of EGMFri 25/10/19 | 09:27
Second Price Monitoring ExtnFri 11/10/19 | 14:05
Price Monitoring ExtensionFri 11/10/19 | 14:00
Matins Trial UpdateWed 09/10/19 | 07:00
Notice of EGMFri 04/10/19 | 07:20
Update on Traumakine drug substance manufacturingWed 02/10/19 | 07:00
MATINS poster presentation at ESMO CongressMon 30/09/19 | 07:00
Holdings in CompanyWed 25/09/19 | 09:13
Interim resultsMon 23/09/19 | 07:08
MATINS study selected for ESMO 2019Mon 02/09/19 | 07:00
Result of Open Offer and Further SubscriptionTue 27/08/19 | 07:00
Holding(s) in CompanyMon 19/08/19 | 09:33
Notice of Interim ResultsFri 16/08/19 | 07:00
Issue of EquityTue 06/08/19 | 13:53
Subscription and Open OfferMon 05/08/19 | 07:00
MATINS study updateFri 12/07/19 | 07:00
Price Monitoring ExtensionFri 05/07/19 | 09:00
Second Price Monitoring ExtnThu 04/07/19 | 16:40
Price Monitoring ExtensionThu 04/07/19 | 16:35
Price Monitoring ExtensionThu 04/07/19 | 14:00
Holdings in CompanyThu 04/07/19 | 09:31
Grant of optionsMon 01/07/19 | 12:10
Phase II INFORAAA study updateWed 26/06/19 | 07:00
Final results from YODA studyFri 14/06/19 | 07:00
Results of AGMTue 28/05/19 | 12:27
AGM update, Board & management changesFri 24/05/19 | 09:32
Grant of OptionsWed 22/05/19 | 12:51
Holding(s) in CompanyTue 21/05/19 | 09:21
Holding(s) in CompanyThu 16/05/19 | 09:16
Holdings in CompanyTue 14/05/19 | 07:01
Share Subscription and Issue of EquityTue 14/05/19 | 07:00
Notice of AGMTue 07/05/19 | 07:05
Final Results for the year ended 31 December 2018Tue 07/05/19 | 07:00
Statement regarding Price MovementThu 02/05/19 | 17:20
Second Price Monitoring ExtnThu 02/05/19 | 14:05
Price Monitoring ExtensionThu 02/05/19 | 14:00
Results from the Japanese Phase III studyMon 29/04/19 | 07:00
Holding(s) in CompanyThu 25/04/19 | 16:09
Holding(s) in CompanyFri 12/04/19 | 13:20
First expansion cohort for MATINS trial part 2Thu 11/04/19 | 07:00
Holding(s) in CompanyWed 10/04/19 | 11:41
Notice of ResultsFri 05/04/19 | 07:00
Holdings in CompanyTue 02/04/19 | 09:23
Holding(s) in CompanyFri 29/03/19 | 07:00
Results of the Placing and SubscriptionThu 28/03/19 | 12:54
Result of Placing and Issue PriceTue 26/03/19 | 15:31
Proposed Placing to raise approximately EUR 3mTue 26/03/19 | 07:00
MATINS study updateThu 21/02/19 | 07:00
Traumakine update - YODA resultsWed 19/12/18 | 07:00
First patient dosed in phase I/II MATINS studyFri 14/12/18 | 11:20
Holding(s) in CompanyTue 11/12/18 | 16:26
Patient subgroup identified from INTEREST trialWed 05/12/18 | 07:00
Faron receives CTA approval for ClevegenMon 03/12/18 | 07:00
PDMR DealingsTue 06/11/18 | 15:52
Second Price Monitoring ExtnTue 23/10/18 | 11:05
Price Monitoring ExtensionTue 23/10/18 | 11:00
Second Price Monitoring ExtnTue 23/10/18 | 09:06
Price Monitoring ExtensionTue 23/10/18 | 09:00
INTEREST trial update presented at ESICMMon 22/10/18 | 15:00
Director/PDMR ShareholdingTue 18/09/18 | 09:23
Faron announces CTA filing for ClevegenMon 17/09/18 | 07:00
Interim ResultsThu 13/09/18 | 07:00
Second Price Monitoring ExtnWed 08/08/18 | 11:05
Price Monitoring ExtensionWed 08/08/18 | 11:00
Notice of Interim ResultsWed 08/08/18 | 07:00
Holding(s) in CompanyMon 09/07/18 | 08:45
Holdings in CompanyFri 22/06/18 | 07:00
Director/PDMR ShareholdingThu 21/06/18 | 15:58
Price Monitoring ExtensionThu 21/06/18 | 09:00
Director/PDMR ShareholdingThu 21/06/18 | 07:40
Second Price Monitoring ExtnWed 20/06/18 | 14:05
Price Monitoring ExtensionWed 20/06/18 | 14:00
Holding(s) in CompanyWed 20/06/18 | 08:43
Holdings in CompanyMon 18/06/18 | 15:42
Second Price Monitoring ExtnFri 15/06/18 | 16:40
Price Monitoring ExtensionFri 15/06/18 | 16:35
Second Price Monitoring ExtnThu 14/06/18 | 11:05
Price Monitoring ExtensionThu 14/06/18 | 11:00
Biomarker analysis of Phase III INTEREST trialThu 14/06/18 | 07:00
Result of AGMThu 31/05/18 | 14:33
PDMR ShareholdingWed 16/05/18 | 17:53
Director/PDMR ShareholdingTue 15/05/18 | 15:14
Second Price Monitoring ExtnTue 15/05/18 | 14:05
Price Monitoring ExtensionTue 15/05/18 | 14:00
Holdings in CompanyTue 15/05/18 | 13:16
Holding(s) in CompanyFri 11/05/18 | 16:51
Holding(s) in CompanyFri 11/05/18 | 13:37
Holding(s) in CompanyFri 11/05/18 | 13:34
Notice of AGMThu 10/05/18 | 10:05
Second Price Monitoring ExtnWed 09/05/18 | 16:40
Price Monitoring ExtensionWed 09/05/18 | 16:35
Holdings in CompanyWed 09/05/18 | 12:54
Second Price Monitoring ExtnTue 08/05/18 | 09:05
Price Monitoring ExtensionTue 08/05/18 | 09:00
Top line data from the Phase III INTEREST trialTue 08/05/18 | 07:00
Final Results for the year ended 31 December 2017Tue 08/05/18 | 07:00
Holdings in CompanyWed 25/04/18 | 12:43
Notice of Full Year ResultsWed 21/03/18 | 07:00
Holding(s) in CompanyTue 06/03/18 | 12:54
Holding(s) in CompanyMon 05/03/18 | 10:12
Holding(s) in CompanyFri 02/03/18 | 13:30
Holding(s) in CompanyFri 02/03/18 | 13:25
Holdings in CompanyThu 01/03/18 | 12:42
Holdings in CompanyThu 01/03/18 | 12:41
Issue of EquityMon 26/02/18 | 13:37
Results of Placing & Issue of EquityWed 21/02/18 | 15:31
Proposed Placing to raise up to £15mFri 16/02/18 | 07:00
FDA grants Fast Track Designation for Traumakine®Mon 29/01/18 | 07:00
FDA approval of Faron's Traumakine® INDWed 24/01/18 | 07:00
INFORAAA trial receives recommendation from IDMCTue 19/12/17 | 07:00
Recruitment completed in Traumakine INTEREST TrialMon 11/12/17 | 07:32
Holding(s) in CompanyWed 06/12/17 | 18:06
Holdings in CompanyFri 01/12/17 | 14:55
Holding(s) in CompanyFri 24/11/17 | 10:23
Grant of optionsTue 21/11/17 | 07:00
Change of AdviserMon 20/11/17 | 07:00
Holding(s) in CompanyMon 16/10/17 | 09:00
Director/PDMR ShareholdingFri 13/10/17 | 09:00
Issue of Equity & PDMR ShareholdingWed 11/10/17 | 14:00
Result of Placing & Subscription & Issue of EquityMon 09/10/17 | 16:30
Proposed Placing and SubscriptionThu 05/10/17 | 07:00
Traumakine Receives PIM Designation from MHRAMon 02/10/17 | 07:00
Directors DealingsMon 11/09/17 | 15:19
Interim ResultsWed 06/09/17 | 07:00
FDA advises Faron to proceed directly to BLAMon 04/09/17 | 07:00
Update on INTEREST Phase III Study from IDMCFri 04/08/17 | 07:00
Holding(s) in CompanyFri 28/07/17 | 09:34
Holding(s) in CompanyMon 10/07/17 | 16:51
Notice of ResultsMon 10/07/17 | 07:00
Director/PDMR ShareholdingFri 16/06/17 | 14:43